Randomized Study of Interleukin 2 (IL-2) Alone vs IL-2 Plus Lymphokine-Activated Killer Cells for Treatment of Melanoma and Renal Cell Cancer
Michael J. Koretz, David H. Lawson, R. Martin York, Sam D. Graham, Douglas R. Murray, Teresa M. Gillespie, Daniel Levitt, Kenneth M. Sell
Research output: Contribution to journal › Article › peer-review
51Scopus
citations
Fingerprint
Dive into the research topics of 'Randomized Study of Interleukin 2 (IL-2) Alone vs IL-2 Plus Lymphokine-Activated Killer Cells for Treatment of Melanoma and Renal Cell Cancer'. Together they form a unique fingerprint.